Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenka Tesarova

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|July 30, 2013
Driven hematopoietic differentiation of embryonic stem cells: epigenetic perspectivesLenka Tesarova, Stanislav Stejskal, Irena Koutna
Plos One|June 24, 2016
The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro CultureLenka Tesarova, Pavel Simara, Stanislav Stejskal, et al.
Cellular Reprogramming|June 21, 2017
Hematopoietic Developmental Potential of Human Pluripotent Stem Cell Lines Is Accompanied by the Morphology of Embryoid Bodies and the Expression of Endodermal and Hematopoietic MarkersLenka Tesarova, Pavel Simara, Stanislav Stejskal, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2010
Multiple myeloma patients at peripheral blood stem cell harvest: restricted usage of TCR beta variable familiesLenka Tesarova, Irena Koutna, Zdenek Koristek, et al.
International Journal of Molecular Sciences|August 1, 2020
Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical ApplicationsLenka Tesarova, Klara Jaresova, Pavel Simara, et al.
Annals of Hematology|September 8, 2010
Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral bloodIrena Koutna, Martina Peterkova, Pavel Simara, et al.
Stem Cell Research & Therapy|March 23, 2017
DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturingPavel Simara, Lenka Tesarova, Daniela Rehakova, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 19, 2021
Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectivenessHana Lejdarova, Rita Pacasova, Lenka Tesarova, et al.
Cell Cycle (Georgetown, Tex.)|December 10, 2015
Cell cycle-dependent changes in H3K56ac in human cellsStanislav Stejskal, Karel Stepka, Lenka Tesarova, et al.
American Journal of Hematology|February 20, 2013
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibitionPavel Simara, Stanislav Stejskal, Irena Koutna, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|July 30, 2013
Driven hematopoietic differentiation of embryonic stem cells: epigenetic perspectivesLenka Tesarova, Stanislav Stejskal, Irena Koutna
Plos One|June 24, 2016
The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro CultureLenka Tesarova, Pavel Simara, Stanislav Stejskal, et al.
Cellular Reprogramming|June 21, 2017
Hematopoietic Developmental Potential of Human Pluripotent Stem Cell Lines Is Accompanied by the Morphology of Embryoid Bodies and the Expression of Endodermal and Hematopoietic MarkersLenka Tesarova, Pavel Simara, Stanislav Stejskal, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2010
Multiple myeloma patients at peripheral blood stem cell harvest: restricted usage of TCR beta variable familiesLenka Tesarova, Irena Koutna, Zdenek Koristek, et al.
International Journal of Molecular Sciences|August 1, 2020
Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical ApplicationsLenka Tesarova, Klara Jaresova, Pavel Simara, et al.
Annals of Hematology|September 8, 2010
Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral bloodIrena Koutna, Martina Peterkova, Pavel Simara, et al.
Stem Cell Research & Therapy|March 23, 2017
DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturingPavel Simara, Lenka Tesarova, Daniela Rehakova, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 19, 2021
Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectivenessHana Lejdarova, Rita Pacasova, Lenka Tesarova, et al.
Cell Cycle (Georgetown, Tex.)|December 10, 2015
Cell cycle-dependent changes in H3K56ac in human cellsStanislav Stejskal, Karel Stepka, Lenka Tesarova, et al.
American Journal of Hematology|February 20, 2013
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibitionPavel Simara, Stanislav Stejskal, Irena Koutna, et al.
Pageof 2